The 2024 MAGI Clinical Research Conference in New Orleans played host to yet another exciting round of clinical trial innovation, with attendees voting on their favorite of five creative approaches in the WCG Innovation Challenge. Read on to learn more about this year’s winner as well as the four finalists.
Read More
Latin American women are playing an important role in shaping clinical research. This article, excerpted from a blog post by WCG site services and Latin America specialists takes a closer look at the obstacles and triumphs and gives voice to some successful Latina researchers. Read More
Making the move to eSource can be a daunting task for a site, making it important to understand what each potential choice offers and how they align with your site’s needs, one trial operations expert advises. Read More
A cargo van designed to serve as a fully functional mobile clinical trial site took the checkered flag as winner of this year’s WCG Innovation Challenge, presented last week at the 2024 MAGI Clinical Research Conference in New Orleans. Read More
Although AI holds great potential in optimizing and advancing clinical research, the risks and ethical concerns it presents must be considered when using it in clinical trials, the World Health Organization (WHO) cautions in a recent report. Read More
To avoid being caught out by sponsors that don’t follow clinical trial regulatory requirements, sites should make sure before they accept a trial that its monitoring, site activation and site coordination efforts are compliant, a lesson driven home by a recent FDA Warning Letter. Read More
Drastic changes in drug development mean quality management approaches are more critical than ever, with meaningful advancement hinging on cultural shifts, crossfunctional alignment and top-down approaches within organizations, as well as thoughtful, stakeholder-informed trial designs. Read More
Boehringer Ingelheim (BI) has done a full 180-degree turn on patient involvement in trial design in recent years, moving from virtually no patient input to incorporating patient feedback in nearly all of its protocols today. The German pharma giant elaborated on how it accomplished this during a session at the 2024 Summit for Clinical Ops Executives (SCOPE). Read More
The recruitment and retention of Bioresearch Monitoring (BIMO) program investigators has been a thorn in the side of the FDA that’s negatively impacted trial inspections, a Government Accountability Office (GAO) audit has found. Read More
Inspired by lackluster efforts to improve diversity, equity and inclusion (DE&I) in clinical research, two centers at the University of Pennsylvania (UPenn) have moved to publish the core methodologies and practices they developed to boost DE&I within their trials. Read More